Clinical Trial Update: A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin [Phase 2]

View source ↗

Summary

Pfizer sponsored a Phase 2 trial to assess the safety and effects of an investigational drug in adults with Type 2 diabetes mellitus taking metformin; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Pfizer | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED